Journal of Clinical Trials : Citations & Metrics Report
Articles published in Journal of Clinical Trials have been cited by esteemed scholars and scientists all around the world. Journal of Clinical Trials has got h-index 22, which means every article in Journal of Clinical Trials has got 22 average citations.
Following are the list of articles that have cited the articles published in Journal of Clinical Trials.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Total published articles |
64 | 66 | 79 | 78 | 38 | 20 | 35 | 52 | 44 | 54 | 25 | 31 | 3 |
Research, Review articles and Editorials |
27 | 33 | 67 | 44 | 22 | 11 | 20 | 39 | 41 | 47 | 19 | 27 | 3 |
Research communications, Review communications, Editorial communications, Case reports and Commentary |
37 | 33 | 12 | 34 | 16 | 9 | 15 | 13 | 3 | 7 | 6 | 4 | 0 |
Conference proceedings |
0 | 5 | 12 | 0 | 15 | 115 | 118 | 56 | 63 | 0 | 0 | 0 | 0 |
Citations received as per Google Scholar, other indexing platforms and portals |
175 | 190 | 167 | 179 | 137 | 137 | 143 | 0 | 0 | 0 | 0 | 0 | 0 |
| Journal total citations count | 1734 |
| Journal impact factor | 2.76 |
| Journal 5 years impact factor | 3.07 |
| Journal cite score | 3.14 |
| Journal h-index | 22 |
| Journal h-index since 2019 | 16 |
Important citations (609)
Using “reader disagreement index” as a predictive reviewer performance monitoring tool for timely intervention |
|
Difference in computed tomography image quality between central vein and peripheral vein enhancement in treatment naive esophageal cancer patients |
|
Reader disagreement index: a better measure of overall review quality monitoring in an oncology trial compared to adjudication rate |
|
Discrepancies of assessments in a recist 1.1 phase ii clinical trial – association between adjudication rate and variability in images and tumors selection |
|
Adjudication rates between readers in blinded independent central review of oncology studies |
|
Hypocalcemia in a patient with metastatic prostate cancer from denosumab treatment |
|
Severe refractory hypocalcemia in a patient with metastatic prostate carcinoma following denosumab injection |
|
Severe hypocalcaemia following denosumab in a patient with cancer with vitamin d deficiency |
|
Hypocalcaemia following denosumab in prostate cancer: a clinical review |
|
Is cardiorespiratory fitness independently associated with the biochemical profile in overweight/obese adults with primary hypertension? the exerdiet-hta study |
|
Assessment of cardiovascular risk and vascular age in overweight/obese adults with primary hypertension: exerdiet-hta study |
|
Validity of the modified shuttle walk test to assess cardiorespiratory fitness after exercise intervention in overweight/obese adults with primary hypertension |
|
Impact on health-related quality of life after different aerobic exercise programs in physically inactive adults with overweight/obesity and primary hypertension: data from the exerdiet-hta study |
|
Physical activity, sedentary behavior, and sleep quality in adults with primary hypertension and obesity before and after an aerobic exercise program: exerdiet-hta study |
|
Association between modified shuttle walk test and cardiorespiratory fitness in overweight/obese adults with primary hypertension: exerdiet-hta study |
|
A metabolically healthy profile is a transient stage when exercise and diet are not supervised: long-term effects in the exerdiet-hta study |
|
Assessment of cardiovascular risk and vascular age in overweight/obese adults with primary hypertension: the exerdiet-hta study |
|
Long-term effects in the exerdiet-hta study: supervised exercise training vs. physical activity advice |
|
Effects of different exercise training programs on cardiorespiratory fitness in overweight/obese adults with hypertension: a pilot study |
|
Different exercise modalities exert opposite acute effects on short-term blood pressure variability in male patients with hypertension |
|